Research and analysis

Human papillomavirus (HPV) immunisation programme review: 2008 to 2014

A review of the first 6 years of the national human papillomavirus (HPV) immunisation programme for adolescent girls in England.

• From: Public Health England
• Published: 13 March 2015

Documents

Human Papillomavirus (HPV) vaccine coverage in England, 2008 to 2014: programme review

Ref: PHE publications gateway number: 2014797

PDF, 1.77 MB, 39 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The human papillomavirus (HPV) vaccination programme’s primary aim is to reduce the incidence of cervical cancer in women. Over 2.3 million girls have received 3 doses of HPV vaccine in England since the start of the programme in September 2008.

This report reviews the success of the programme and the lessons that can be learned to strengthen it in future, as well as presenting UK summary data from 1 September 2008 to 31 August 2014.

Published 13 March 2015